| 规格: | 98% |
| 分子量: | N/A |
| 包装 | 价格(元) |
| 100ug | 电议 |
| 500ug | 电议 |
Background:
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of spike protein and ACE2 is a potential therapeutic approach for SARS-CoV-2 treatment[1].
[1]. Chunyan Wang, et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nat Commun. 2020 May 4;11(1):2251.
